Phio Pharmaceuticals (PHIO) EBITDA (2011 - 2026)
Phio Pharmaceuticals (PHIO) EBITDA from Jun 30, 2011 to Mar 31, 2026. The TTM Phio Pharmaceuticals (PHIO) EBITDA is -$12M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Phio Pharmaceuticals (PHIO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +63.40% |
| 3 Years TTM | -2.35% |
| 5 Years TTM | +2.87% |
| 10 Years TTM | +1.98% |
| All Time TTM | +0.01% |
Annual EBITDA change of Phio Pharmaceuticals (PHIO)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$4.17M | -54.77% |
| 2025 | -$9.22M | +24.93% |
| 2024 | -$7.38M | -31.48% |
| 2023 | -$11M | -5.44% |
| 2022 | -$11M | -15.25% |
| 2021 | -$13M | +54.13% |
| 2020 | -$8.72M | -2.24% |
| 2019 | -$8.92M | +22.53% |
| 2018 | -$7.28M | -47.96% |
| 2017 | -$14M | +56.14% |
| 2016 | -$8.96M | -11.81% |
| 2015 | -$10M | +16.25% |
| 2014 | -$8.74M | -58.08% |
| 2013 | -$21M | +62.51% |
| 2012 | -$13M | +1.74% |
| 2011 | -$13M | +5.17% |
| 2010 | -$12M | -34.80% |
| 2009 | -$18M | +27.97% |
| 2008 | -$14M | +30.76% |
| 2007 | -$11M | +357.92% |
| 2006 | -$2.40M | +8.60% |
| 2005 | -$2.21M | -32.42% |
| 2004 | -$3.27M | +3533.33% |
| 2003 | -$90K | N/A |
Comparison Phio Pharmaceuticals (PHIO) five years EBITDA CAGR with competitors
Phio Pharmaceuticals (PHIO) five years EBITDA CAGR is 2.85%.